Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipients
- PMID: 7149107
- DOI: 10.4269/ajtmh.1982.31.1229
Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipients
Abstract
Colonized Aedes aegypti mosquitoes were fed on voluntary recipients of an experimental, live, attenuated, dengue type 2 (PR 159/S-1) vaccine to estimate the frequency of vector infection and the stability of the virus in mosquitoes. Two volunteers were viremic at the time of mosquito feeding, but only two of 114 mosquitoes that took a viremic blood meal became infected with the vaccine virus. Strains of virus recovered from the bodies of the mosquitoes and the volunteer's blood retained the temperature sensitivity and small plaque growth characteristics of the vaccine virus. Dengue viral antigen was not detectable in any of the mosquito heads by direct immunofluorescence and in vitro virus transmission by droplet feeding was not observed. This experiment showed that vector mosquitoes can be infected with vaccine virus by feeding on viremic vaccinees. Furthermore, the virus is sufficiently stable to retain the in vitro growth characteristics associated with the vaccine virus.
Similar articles
-
Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegypti.Am J Trop Med Hyg. 1982 Nov;31(6):1232-7. doi: 10.4269/ajtmh.1982.31.1232. Am J Trop Med Hyg. 1982. PMID: 7149108
-
Limited potential for transmission of live dengue virus vaccine candidates by Aedes aegypti and Aedes albopictus.Am J Trop Med Hyg. 2000 Jun;62(6):698-701. doi: 10.4269/ajtmh.2000.62.698. Am J Trop Med Hyg. 2000. PMID: 11304057
-
Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti.Am J Trop Med Hyg. 1999 Oct;61(4):672-6. doi: 10.4269/ajtmh.1999.61.672. Am J Trop Med Hyg. 1999. PMID: 10548309
-
Diagnostic methods for detection & isolation of dengue viruses from vector mosquitoes.Indian J Med Res. 2006 May;123(5):615-28. Indian J Med Res. 2006. PMID: 16873905 Review.
-
Approaches of dengue control: vaccine strategies and future aspects.Front Immunol. 2024 Feb 29;15:1362780. doi: 10.3389/fimmu.2024.1362780. eCollection 2024. Front Immunol. 2024. PMID: 38487527 Free PMC article. Review.
Cited by
-
Understanding the dengue viruses and progress towards their control.Biomed Res Int. 2013;2013:690835. doi: 10.1155/2013/690835. Epub 2013 Jul 9. Biomed Res Int. 2013. PMID: 23936833 Free PMC article. Review.
-
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.J Virol. 2000 Apr;74(7):3011-9. doi: 10.1128/jvi.74.7.3011-3019.2000. J Virol. 2000. PMID: 10708415 Free PMC article.
-
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.J Virol. 2000 Apr;74(7):3020-8. doi: 10.1128/jvi.74.7.3020-3028.2000. J Virol. 2000. PMID: 10708416 Free PMC article.
-
Considerations for Human Blood-Feeding and Arthropod Exposure in Vector Biology Research: An Essential Tool for Investigations and Disease Control.Vector Borne Zoonotic Dis. 2020 Nov;20(11):807-816. doi: 10.1089/vbz.2020.2620. Epub 2020 Sep 9. Vector Borne Zoonotic Dis. 2020. PMID: 32905735 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials